Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Sander van Deventer

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Mice

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Huibregtse Inge L; Marietta Eric V; Rashtak Shadi; Koning Frits; Rottiers Pieter; David Chella S; van Deventer Sander J H; Murray Joseph A
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice.
Levels Johannes H M; Pajkrt Dasja; Schultz Marcus; Hoek Frans J; van Tol Arie; Meijers Joost C M; van Deventer Sander J H
Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis.
Bleuming Sylvia A; He Xi C; Kodach Liudmila L; Hardwick James C; Koopman Frieda A; Ten Kate Fiebo J; van Deventer Sander J H; Hommes Daniel W; Peppelenbosch Maikel P; Offerhaus G Johan; Li Linheng; van den Brink Gijs R
Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Sander van Deventer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Huibregtse Inge L; Marietta Eric V; Rashtak Shadi; Koning Frits; Rottiers Pieter; David Chella S; van Deventer Sander J H; Murray Joseph A
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2390-6.
2007: Levels Johannes H M; Pajkrt Dasja; Schultz Marcus; Hoek Frans J; van Tol Arie; Meijers Joost C M; van Deventer Sander J H
Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis.
Biochimica et biophysica acta 2007;1771(12):1429-38.
2007: Bleuming Sylvia A; He Xi C; Kodach Liudmila L; Hardwick James C; Koopman Frieda A; Ten Kate Fiebo J; van Deventer Sander J H; Hommes Daniel W; Peppelenbosch Maikel P; Offerhaus G Johan; Li Linheng; van den Brink Gijs R
Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice.
Cancer research 2007;67(17):8149-55.
2007: Gelderblom Huub C; Nijhuis Laurens E J; de Jong Esther C; te Velde Anje A; Pajkrt Dasja; Reesink Henk W; Beld Marcel G H M; van Deventer Sander J H; Jansen Peter L M
Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(7):944-53.
2007: Huibregtse Inge L; Snoeck Veerle; de Creus An; Braat Henri; De Jong Ester C; Van Deventer Sander J H; Rottiers Pieter
Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Gastroenterology 2007;133(2):517-28.
2007: de Ridder Lissy; Benninga Marc A; Taminiau Jan A J M; Hommes Daan W; van Deventer Sander J H
Infliximab use in children and adolescents with inflammatory bowel disease.
Journal of pediatric gastroenterology and nutrition 2007;45(1):3-14.
2007: Milano Francesca; van Baal Jantine W P M; Rygiel Agnieszka M; Bergman Jacques J G H M; Van Deventer Sander J H; Kapsenberg Martien L; Peppelenbosch Maikel P; Krishnadath Kausilia K
An improved protocol for generation of immuno-potent dendritic cells through direct electroporation of CD14+ monocytes.
Journal of immunological methods 2007;321(1-2):94-106.
2007: Van den Brande Jan M H; Koehler Tamara C; Zelinkova Zuzana; Bennink Roelof J; te Velde Anje A; ten Cate Fibo J W; van Deventer Sander J H; Peppelenbosch Maikel P; Hommes Daniël W
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease.
Gut 2007;56(4):509-17.
2007: Huibregtse I L; van Lent A U; van Deventer S J H
Immunopathogenesis of IBD: insufficient suppressor function in the gut?
Gut 2007;56(4):584-92.
2007: Dekker E; van den Broek F J; Reitsma J B; Hardwick J C; Offerhaus G J; van Deventer S J; Hommes D W; Fockens P
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis.
Endoscopy 2007;39(3):216-21.
2007: te Velde Anje A; de Kort Floor; Sterrenburg Ellen; Pronk Inge; ten Kate Fiebo J W; Hommes Daniel W; van Deventer Sander J H
Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease.
Inflammatory bowel diseases 2007;13(3):325-30.
2007: Braat Henri; McGuirk Peter; Ten Kate Fiebo J W; Huibregtse Inge; Dunne Padraic J; Hommes Daan W; Van Deventer Sander J H; Mills Kingston H G
Prevention of experimental colitis by parenteral administration of a pathogen-derived immunomodulatory molecule.
Gut 2007;56(3):351-7.
2006: Kwakman Paulus H S; te Velde Anje A; Vandenbroucke-Grauls Christina M J E; van Deventer Sander J H; Zaat Sebastian A J
Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2.
Antimicrobial agents and chemotherapy 2006;50(12):3977-83.
2006: Löwenberg Mark; Verhaar Auke P; Bilderbeek Joyce; Marle Jan van; Buttgereit Frank; Peppelenbosch Maikel P; van Deventer Sander J; Hommes Daniel W
Glucocorticoids cause rapid dissociation of a T-cell-receptor-associated protein complex containing LCK and FYN.
EMBO reports 2006;7(10):1023-9.
2006: van Gemert-Horsthuis Karin; Florie Jasper; Hommes Daniel W; Lavini Cristina; Reitsma Johannes B; van Deventer Sander J; Stoker Jaap
Feasibility of evaluating Crohn's disease activity at 3.0 Tesla.
Journal of magnetic resonance imaging : JMRI 2006;24(2):340-8.
2006: Reinisch W; Hommes D W; Van Assche G; Colombel J-F; Gendre J-P; Oldenburg B; Teml A; Geboes K; Ding H; Zhang L; Tang M; Cheng M; van Deventer S J H; Rutgeerts P; Pearce T
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease.
Gut 2006;55(8):1138-44.
2006: Löwenberg Mark; Tuynman Jurriaan; Scheffer Meike; Verhaar Auke; Vermeulen Louis; van Deventer Sander; Hommes Daniel; Peppelenbosch Maikel
Kinome analysis reveals nongenomic glucocorticoid receptor-dependent inhibition of insulin signaling.
Endocrinology 2006;147(7):3555-62.
2006: Braat Henri; Rottiers Pieter; Hommes Daniel W; Huyghebaert Nathalie; Remaut Erik; Remon Jean-Paul; van Deventer Sander J H; Neirynck Sabine; Peppelenbosch Maikel P; Steidler Lothar
A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(6):754-9.
2006: van Deventer S J H; Wedel M K; Baker B F; Xia S; Chuang E; Miner P B
A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.
Alimentary pharmacology & therapeutics 2006;23(10):1415-25.
2006: Stokkers Pieter C F; Deley Maartje; Van Der Spek Mirjam; Verberne Hein J; Van Deventer Sander J H; Hommes Daniel W
Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.
Scandinavian journal of gastroenterology 2006;41(2):200-4.
2006: van Rijn Jeroen C; Reitsma Johannes B; Stoker Jaap; Bossuyt Patrick M; van Deventer Sander J; Dekker Evelien
Polyp miss rate determined by tandem colonoscopy: a systematic review.
The American journal of gastroenterology 2006;101(2):343-50.
2006: Derijks Luc J J; Gilissen Lennard P L; Engels Leopold G J B; Bos Laurens P; Bus Paul J; Lohman Joseph J H M; van Deventer Sander J H; Hommes Daniel W; Hooymans Piet M
Pharmacokinetics of 6-thioguanine in patients with inflammatory bowel disease.
Therapeutic drug monitoring 2006;28(1):45-50.
2006: Zelinkova Zuzana; Derijks Luc J J; Stokkers Pieter C F; Vogels Esther W M; van Kampen Antoine H C; Curvers Wouter L; Cohn Danny; van Deventer Sander J H; Hommes Daniël W
Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2006;4(1):44-9.
2005: Florie Jasper; Horsthuis Karin; Hommes Daniel W; Nio C Yung; Reitsma Johannes B; van Deventer Sander J; Stoker Jaap
Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(12):1221-8.
2005: Sandborn William J; Colombel Jean Frédéric; Enns Roberts; Feagan Brian G; Hanauer Stephen B; Lawrance Ian C; Panaccione Remo; Sanders Martin; Schreiber Stefan; Targan Stephan; van Deventer Sander; Goldblum Ronald; Despain Darrin; Hogge Gary S; Rutgeerts Paul;
Natalizumab induction and maintenance therapy for Crohn's disease.
The New England journal of medicine 2005;353(18):1912-25.
2005: Willemsen L E M; Hoetjes J P; van Deventer S J H; van Tol E A F
Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition.
Clinical and experimental immunology 2005;142(2):275-84.
2005: van Baal Jantine W P M; Milano Francesca; Rygiel Agnieszka M; Bergman Jacques J G H M; Rosmolen Wilda D; van Deventer Sander J H; Wang Kenneth K; Peppelenbosch Maikel P; Krishnadath Kausilia K
A comparative analysis by SAGE of gene expression profiles of Barrett's esophagus, normal squamous esophagus, and gastric cardia.
Gastroenterology 2005;129(4):1274-81.
2005: Löwenberg Mark; Tuynman Jurriaan; Bilderbeek Joyce; Gaber Timo; Buttgereit Frank; van Deventer Sander; Peppelenbosch Maikel; Hommes Daniel
Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn.
Blood 2005;106(5):1703-10.
2005: Löwenberg Mark; Verhaar Auke; van den Blink Bernt; ten Kate Fibo; van Deventer Sander; Peppelenbosch Maikel; Hommes Daniel
Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(4):2293-300.
2005: Braat Henri; Stokkers Pieter; Hommes Tijmen; Cohn Danny; Vogels Esther; Pronk Inge; Spek Arnold; van Kampen Antoine; van Deventer Sander; Peppelenbosch Maikel; Hommes Daan
Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients.
Journal of molecular medicine (Berlin, Germany) 2005;83(8):601-9.
2005: Kara Mohammed A; Peters Femke P; Ten Kate Fiebo J W; Van Deventer Sander J; Fockens Paul; Bergman Jacques J G H M
Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus.
Gastrointestinal endoscopy 2005;61(6):679-85.
2005: Peters Femke P; Kara Mohammed A; Rosmolen Wilda D; Aalders Maurice C G; Ten Kate Fiebo J W; Bultje Bert C; Krishnadath Kausilia K; Fockens Paul; van Lanschot Jan J B; van Deventer Sander J H; Bergman Jacques J G H M
Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus.
Gastrointestinal endoscopy 2005;61(4):506-14.
2005: Levels J H M; Marquart J A; Abraham P R; van den Ende A E; Molhuizen H O F; van Deventer S J H; Meijers J C M
Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.
Infection and immunity 2005;73(4):2321-6.
2005: Bennink Roelof J; Hamann Jörg; de Bruin Kora; ten Kate Fiebo J W; van Deventer Sander J H; te Velde Anje A
Dedicated pinhole SPECT of intestinal neutrophil recruitment in a mouse model of dextran sulfate sodium-induced colitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(3):526-31.
2005: de Visser M; van Ballegooijen M; Bloemers S M; van Deventer S J H; Jansen J B M J; Jespersen J; Kluft C; Meijer G A; Stoker J; de Valk G A; Verweij M F; Vlems F A
Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT.
Cellular oncology : the official journal of the International Society for Cellular Oncology 2005;27(1):17-29.
2004: Braat Henri; van den Brande Jan; van Tol Erik; Hommes Daan; Peppelenbosch Maikel; van Deventer Sander
Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function.
The American journal of clinical nutrition 2004;80(6):1618-25.
2004: Maartense Stefan; Dunker Michalda S; Slors J Frederick; Cuesta Miguel A; Gouma Dirk J; van Deventer Sander J; van Bodegraven Ad A; Bemelman Willem A
Hand-assisted laparoscopic versus open restorative proctocolectomy with ileal pouch anal anastomosis: a randomized trial.
Annals of surgery 2004;240(6):984-91; discussion 991-2.
2004: van Deventer S J H; Tami J A; Wedel M K
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis.
Gut 2004;53(11):1646-51.
2004: Peppelenbosch M P; van Deventer S J H
T cell apoptosis and inflammatory bowel disease.
Gut 2004;53(11):1556-8.
2004: Sands Bruce E; Blank Marion A; Patel Kam; van Deventer Sander J;
Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(10):912-20.
2004: van Montfrans Catherine; Bennink Roelof J; de Bruin Kora; de Jonge Wouter; Verberne Hein J; Ten Kate Fiebo J W; van Deventer Sander J H; Te Velde Anje A
In vivo evaluation of 111In-labeled T-lymphocyte homing in experimental colitis.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(10):1759-65.
2004: de Jonge Wouter J; The Frans O; van der Coelen Dennis; Bennink Roelof J; Reitsma Pieter H; van Deventer Sander J; van den Wijngaard René M; Boeckxstaens Guy E
Mast cell degranulation during abdominal surgery initiates postoperative ileus in mice.
Gastroenterology 2004;127(2):535-45.
2004: Van Gelder Rogier E; Nio C Yung; Florie Jasper; Bartelsman Joep F; Snel Pleun; De Jager Steven W; Van Deventer Sander J; Laméris Johan S; Bossuyt Patrick M M; Stoker Jaap
Computed tomographic colonography compared with colonoscopy in patients at increased risk for colorectal cancer.
Gastroenterology 2004;127(1):41-8.
2004: Hardwick James C H; van Santen Marije; van den Brink Gijs R; van Deventer Sander J H; Peppelenbosch Maikel P
DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1.
Carcinogenesis 2004;25(7):1293-8.
2004: Derijks Luc J J; Gilissen Lennard P L; Engels Leopold G J B; Bos Laurens P; Bus Paul J; Lohman Joseph J H M; Curvers Wouter L; Van Deventer Sander J H; Hommes Daniel W; Hooymans Piet M
Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy.
Therapeutic drug monitoring 2004;26(3):311-8.
2004: Ten Hove Tessa; The Olle F; Berkhout Marloes; Bruggeman Joost P; Vyth-Dreese Florry A; Slors J Frederik M; Van Deventer Sander J H; Te Velde Anje A
Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.
Journal of leukocyte biology 2004;75(6):1010-5.
2004: Hommes Daniel W; Sterringa Gerben; van Deventer Sander J H; Tytgat Guido N J; Weel Jan
The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research.
Inflammatory bowel diseases 2004;10(3):245-50.
2004: Hommes Daniel W; van Deventer Sander J H
Endoscopy in inflammatory bowel diseases.
Gastroenterology 2004;126(6):1561-73.
2004: van den Brink Gijs R; Bleuming Sylvia A; Hardwick James C H; Schepman Berber L; Offerhaus G Johan; Keller Josbert J; Nielsen Corinne; Gaffield William; van Deventer Sander J H; Roberts Drucilla J; Peppelenbosch Maikel P
Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation.
Nature genetics 2004;36(3):277-82.
2004: Braat Henri; de Jong Esther C; van den Brande Jan M H; Kapsenberg Martien L; Peppelenbosch Maikel P; van Tol Eric A F; van Deventer Sander J H
Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function.
Journal of molecular medicine (Berlin, Germany) 2004;82(3):197-205.
2004: van Montfrans Catherine; te Velde Anje A; van Deventer Sander J H; Rodriguez Pena Maria Sol
Gene therapy in the treatment of intestinal inflammation.
International journal of colorectal disease 2004;19(2):79-86.
2004: Erkelens G W; van Deventer S J H
Endoscopic treatment of strictures in Crohn's disease.
Best practice & research. Clinical gastroenterology 2004;18(1):201-7.
2004: Sands Bruce E; Anderson Frank H; Bernstein Charles N; Chey William Y; Feagan Brian G; Fedorak Richard N; Kamm Michael A; Korzenik Joshua R; Lashner Bret A; Onken Jane E; Rachmilewitz Daniel; Rutgeerts Paul; Wild Gary; Wolf Douglas C; Marsters Paul A; Travers Suzanne B; Blank Marion A; van Deventer Sander J
Infliximab maintenance therapy for fistulizing Crohn's disease.
The New England journal of medicine 2004;350(9):876-85.
2004: van den Blink Bernt; Branger Judith; Weijer Sebastiaan; Gupta Abhya; van Deventer Sander J H; Peppelenbosch Maikel P; van der Poll Tom
P38 mitogen activated protein kinase is involved in the downregulation of granulocyte CXC chemokine receptors 1 and 2 during human endotoxemia.
Journal of clinical immunology 2004;24(1):37-41.
2004: Bennink Roelof J; van Montfrans Catherine; de Jonge Wouter J; de Bruin Kora; van Deventer Sander J; te Velde Anje A
Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.
Nuclear medicine and biology 2004;31(1):93-101.
2004: Hardwick James C H; Van Den Brink Gijs R; Bleuming Sylvia A; Ballester Isabel; Van Den Brande Jan M H; Keller Josbert J; Offerhaus G Johan A; Van Deventer Sander J H; Peppelenbosch Maikel P
Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.
Gastroenterology 2004;126(1):111-21.
2003: Diks Sander H; Hardwick James C; Diab Remco M; van Santen Marije M; Versteeg Henri H; van Deventer Sander J H; Richel Dick J; Peppelenbosch Maikel P
Activation of the canonical beta-catenin pathway by histamine.
The Journal of biological chemistry 2003;278(52):52491-6.
2003: de Jonge Wouter J; van den Wijngaard René M; The Frans O; ter Beek Merel-Linde; Bennink Roel J; Tytgat Guido N J; Buijs Ruud M; Reitsma Pieter H; van Deventer Sander J; Boeckxstaens Guy E
Postoperative ileus is maintained by intestinal immune infiltrates that activate inhibitory neural pathways in mice.
Gastroenterology 2003;125(4):1137-47.
2003: Willemsen L E M; Koetsier M A; van Deventer S J H; van Tol E A F
Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.
Gut 2003;52(10):1442-7.
2003: Dunker M S; Ten Hove T; Bemelman W A; Slors J F M; Gouma D J; Van Deventer S J H
Interleukin-6, C-reactive protein, and expression of human leukocyte antigen-DR on peripheral blood mononuclear cells in patients after laparoscopic vs. conventional bowel resection: a randomized study.
Diseases of the colon and rectum 2003;46(9):1238-44.
2003: Hommes Daniël W; van Deventer Sander J H
Targeting tumor necrosis factor-alpha in inflammatory bowel disease: why, how, and when?
Current opinion in gastroenterology 2003;19(4):350-7.
2003: Olszyna Dariusz P; Verbon Annelies; Pribble John P; Turner Terence; Axtelle Tim; van Deventer Sander J H; van der Poll Tom
Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia.
European cytokine network 2003;14(3):158-62.
2003: Rutgeerts P; Van Deventer S; Schreiber S
Review article: the expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition.
Alimentary pharmacology & therapeutics 2003;17(12):1435-50.
2003: Van den Brande Jan M H; Braat Henri; van den Brink Gijs R; Versteeg Henri H; Bauer Christiaan A; Hoedemaeker Inge; van Montfrans Catherine; Hommes Daan W; Peppelenbosch Maikel P; van Deventer Sander J H
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease.
Gastroenterology 2003;124(7):1774-85.
2003: Levels Johannes H M; Lemaire Luciënne C J M; van den Ende Abraham E; van Deventer Sander J H; van Lanschot J Jan B
Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure.
Critical care medicine 2003;31(6):1647-53.
2003: van Berkel A M; Bruno M J; Bergman J J G H M; van Deventer S J; Tytgat G N J; Huibregtse K
A prospective randomized study of hydrophilic polymer-coated polyurethane versus polyethylene stents in distal malignant biliary obstruction.
Endoscopy 2003;35(6):478-82.
2003: Levels Johannes H M; Abraham Philip R; van Barreveld Erik P; Meijers Joost C M; van Deventer Sander J H
Distribution and kinetics of lipoprotein-bound lipoteichoic acid.
Infection and immunity 2003;71(6):3280-4.
2003: Branger Judith; van den Blink Bernt; Weijer Sebastiaan; Gupta Abhya; van Deventer Sander J H; Hack C Erik; Peppelenbosch Maikel P; van der Poll Tom
Inhibition of coagulation, fibrinolysis, and endothelial cell activation by a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
Blood 2003;101(11):4446-8.
2003: Versteeg H H; Bresser H L; Spek C A; Richel D J; Van Deventer S J H; Peppelenbosch M P
Regulation of the p21Ras-MAP kinase pathway by factor VIIa.
Journal of thrombosis and haemostasis : JTH 2003;1(5):1012-8.
2003: Hommes D W; van Deventer S J H
Infliximab therapy in Crohn's disease: safety issues.
The Netherlands journal of medicine 2003;61(4):100-4.
2003: van de Scheur M R; van der Waal R I F; van der Waal I; Stoof T J; van Deventer S J H
Ano-genital granulomatosis: the counterpart of oro-facial granulomatosis.
Journal of the European Academy of Dermatology and Venereology : JEADV 2003;17(2):184-9.
2003: van Deventer S J H
New biological therapies in inflammatory bowel disease.
Best practice & research. Clinical gastroenterology 2003;17(1):119-30.
2003: te Velde Anje A; van Kooyk Yvette; Braat Henri; Hommes Daan W; Dellemijn Trees A M; Slors J Frederik M; van Deventer Sander J H; Vyth-Dreese Florry A
Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12-IL-18- dendritic cell populations in the colonic mucosa of patients with Crohn's disease.
European journal of immunology 2003;33(1):143-51.
2003: Verbon Annelies; Meijers Joost C M; Spek C Arnold; Hack C Erik; Pribble John P; Turner Terence; Dekkers Pascale E P; Axtelle Tim; Levi Marcel; van Deventer Sander J H; Reitsma Pieter H; van der Poll Tom
Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
The Journal of infectious diseases 2003;187(1):55-61.
2003: Zwijnenburg Petra J G; Polfliet Machteld M J; Florquin Sandrine; van den Berg Timo K; Dijkstra Christine D; van Deventer Sander J H; Roord John J; van der Poll Tom; van Furth A Marceline
CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats.
Immunology letters 2003;85(1):1-4.
2003: Hommes D W; Peppelenbosch M P; van Deventer S J H
Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.
Gut 2003;52(1):144-51.
2002: van Deventer S J H
Taming the mucosal immune response in Crohn's disease.
Best practice & research. Clinical gastroenterology 2002;16(6):1035-43.
2002: Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
IL-10 gene therapy prevents TNBS-induced colitis.
Gene therapy 2002;9(24):1715-21.
2002: Van Montfrans Catherine; Hooijberg Erik; Rodriguez Pena Maria Sol; De Jong Esther C; Spits Hergen; Te Velde Anje A; Van Deventer Sander J H
Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer.
Gastroenterology 2002;123(6):1877-88.
2002: Van Montfrans Catherine; Rodriguez Pena Maria Sol; Pronk Inge; Ten Kate Fiebo J W; Te Velde Anje A; Van Deventer Sander J H
Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Gastroenterology 2002;123(6):1865-76.
2002: Van Den Blink Bernt; Ten Hove Tessa; Van Den Brink Gijs R; Peppelenbosch Maikel P; Van Deventer Sander J H
From extracellular to intracellular targets, inhibiting MAP kinases in treatment of Crohn's disease.
Annals of the New York Academy of Sciences 2002;973():349-58.
2002: Van Den Brande Jan M H; Peppelenbosch Maikel P; Van Deventer Sander J H
Treating Crohn's disease by inducing T lymphocyte apoptosis.
Annals of the New York Academy of Sciences 2002;973():166-80.
2002: de Jonge Wouter J; Kwikkers Karin L; te Velde Anje A; van Deventer Sander J H; Nolte Martijn A; Mebius Reina E; Ruijter Jan M; Lamers Marinus C; Lamers Wouter H
Arginine deficiency affects early B cell maturation and lymphoid organ development in transgenic mice.
The Journal of clinical investigation 2002;110(10):1539-48.
2002: van den Brink G R; Hardwick J C H; Nielsen C; Xu C; ten Kate F J; Glickman J; van Deventer S J H; Roberts D J; Peppelenbosch M P
Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract.
Gut 2002;51(5):628-33.
2002: Willemsen L E M; Schreurs C C H M; Kroes H; Spillenaar Bilgen E J; Van Deventer S J H; Van Tol E A F
A coculture model mimicking the intestinal mucosa reveals a regulatory role for myofibroblasts in immune-mediated barrier disruption.
Digestive diseases and sciences 2002;47(10):2316-24.
2002: Jellema Wilbert T; Veerman D Peter; De Winter Robbert J; Wesseling Karel H; Van Deventer Sander J H; Hack C Erik; van Lieshout Johannes J
In vivo interaction of endotoxin and recombinant bactericidal/permeability-increasing protein (rBPI23): hemodynamic effects in a human endotoxemia model.
The Journal of laboratory and clinical medicine 2002;140(4):228-35.
2002: ten Hove Tessa; Drillenburg Paul; Wijnholds Jan; Te Velde Anje A; van Deventer Sander J H
Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis.
Digestive diseases and sciences 2002;47(9):2056-63.
2002: van Montfrans Catherine; Peppelenbosch Maikel; te Velde Anje A; van Deventer Sander
Inflammatory signal transduction in Crohn's disease and novel therapeutic approaches.
Biochemical pharmacology 2002;64(5-6):789-95.
2002: van Deventer S J H
Anti-tumour necrosis factor therapy in Crohn's disease: where are we now?
Gut 2002;51(3):362-3.
2002: van Deventer S J H
The future of inflammatory bowel disease therapy.
Inflammatory bowel diseases 2002;8(4):301-5; discussion 306.
2002: van Deventer S J H
A place for TACE.
Gut 2002;51(1):5-6.
2002: van Balkom B P J; Schoon E J; Stockbrügger R W; Wolters F L; van Hogezand R A; van Deventer S J H; Oldenburg B; van Dullemen H M; Russel M G V M
Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.
Alimentary pharmacology & therapeutics 2002;16(6):1101-7.
2002: van Deventer S J H
Small therapeutic molecules for the treatment of inflammatory bowel disease.
Gut 2002;50 Suppl 3():III47-53.
2002: Branger Judith; van den Blink Bernt; Weijer Sebastiaan; Madwed Jeffrey; Bos Carina L; Gupta Abhya; Yong Chan-Loi; Polmar Stephen H; Olszyna Dariusz P; Hack C Erik; van Deventer Sander J H; Peppelenbosch Maikel P; van der Poll Tom
Anti-inflammatory effects of a p38 mitogen-activated protein kinase inhibitor during human endotoxemia.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(8):4070-7.
2002: Escher Johanna C; Stoof Tom J; van Deventer Sander J H; van Furth A Marcelien
Successful treatment of metastatic Crohn disease with infliximab.
Journal of pediatric gastroenterology and nutrition 2002;34(4):420-3.
2002: Corbaz Anne; ten Hove Tessa; Herren Suzanne; Graber Pierre; Schwartsburd Boris; Belzer Ilana; Harrison Jillian; Plitz Thomas; Kosco-Vilbois Marie H; Kim Soo-Hyun; Dinarello Charles A; Novick Daniela; van Deventer Sander; Chvatchko Yolande
IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(7):3608-16.
2002: ten Hove T; van den Blink B; Pronk I; Drillenburg P; Peppelenbosch M P; van Deventer S J H
Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.
Gut 2002;50(4):507-12.
2002: Hommes Daan W; van de Heisteeg Brenda H; van der Spek Mirjam; Bartelsman Joep F W M; van Deventer Sander J H
Infliximab treatment for Crohn's disease: one-year experience in a Dutch academic hospital.
Inflammatory bowel diseases 2002;8(2):81-6.
2002: ten Hove T; van Montfrans C; Peppelenbosch M P; van Deventer S J H
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.
Gut 2002;50(2):206-11.
2002: Tilg H; van Montfrans C; van den Ende A; Kaser A; van Deventer S J H; Schreiber S; Gregor M; Ludwiczek O; Rutgeerts P; Gasche C; Koningsberger J C; Abreu L; Kuhn I; Cohard M; LeBeaut A; Grint P; Weiss G
Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma.
Gut 2002;50(2):191-5.
2002: Camoglio Luisa; Juffermans Nicole P; Peppelenbosch Maikel; te Velde Anje A; ten Kate Fibo J; van Deventer Sander J H; Kopf Manfred
Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis.
European journal of immunology 2002;32(1):261-9.
2002: Hommes Daan; van den Blink Bernt; Plasse Terry; Bartelsman Joep; Xu Cuiping; Macpherson Bret; Tytgat Guido; Peppelenbosch Mailkel; Van Deventer Sander
Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease.
Gastroenterology 2002;122(1):7-14.
2002: van den Brink Gijs R; van den Boogaardt Daniëlle E M; van Deventer Sander J H; Peppelenbosch Maikel P
Feed a cold, starve a fever?
Clinical and diagnostic laboratory immunology 2002;9(1):182-3.
2002: Rijneveld Anita W; Lauw Fanny N; Schultz Marc J; Florquin Sandrine; Te Velde Anje A; Speelman Peter; Van Deventer Sander J H; Van Der Poll Tom
The role of interferon-gamma in murine pneumococcal pneumonia.
The Journal of infectious diseases 2002;185(1):91-7.
2002: Lauw Fanny N; Branger Judith; Florquin Sandrine; Speelman Peter; van Deventer Sander J H; Akira Shizuo; van der Poll Tom
IL-18 improves the early antimicrobial host response to pneumococcal pneumonia.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(1):372-8.
2002: Juffermans Nicole P; Leemans Jaklien C; Florquin Sandrine; Verbon Annelies; Kolk Arend H; Speelman Peter; van Deventer Sander J H; van der Poll Tom
CpG oligodeoxynucleotides enhance host defense during murine tuberculosis.
Infection and immunity 2002;70(1):147-52.
2001: Ten Hove T; Corbaz A; Amitai H; Aloni S; Belzer I; Graber P; Drillenburg P; van Deventer S J; Chvatchko Y; Te Velde A A
Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-alpha production in mice.
Gastroenterology 2001;121(6):1372-9.
2001: Yuan Y H; ten Hove T; The F O; Slors J F; van Deventer S J; te Velde A A
Chemokine receptor CXCR3 expression in inflammatory bowel disease.
Inflammatory bowel diseases 2001;7(4):281-6.
2001: Rijneveld A W; Florquin S; Branger J; Speelman P; Van Deventer S J; van der Poll T
TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):5240-6.
2001: Olszyna D P; Vermeulen H; Baan A H; Speelman P; van Deventer S J; Gouma D J; van der Poll T
Urine interleukin-8 is a marker for urinary tract infection in postoperative patients.
Infection 2001;29(5):274-7.
2001: Schultz M J; Rijneveld A W; Florquin S; Speelman P; Van Deventer S J; van der Poll T
Impairment of host defence by exotoxin A in Pseudomonas aeruginosa pneumonia in mice.
Journal of medical microbiology 2001;50(9):822-7.
2001: Lauw F N; Florquin S; Speelman P; van Deventer S J; van der Poll T
Role of endogenous interleukin-12 in immune response to staphylococcal enterotoxin B in mice.
Infection and immunity 2001;69(9):5949-52.
2001: van den Brink G R; Hardwick J C; Tytgat G N; Brink M A; Ten Kate F J; Van Deventer S J; Peppelenbosch M P
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse.
Gastroenterology 2001;121(2):317-28.
2001: Olszyna D P; Pajkrt D; van Deventer S J; van der Poll T
Effect of interleukin 10 on the release of the CXC chemokines growth related oncogene GRO-alpha and epithelial cell-derived neutrophil activating peptide (ENA)-78 during human endotoxemia.
Immunology letters 2001;78(1):41-4.
2001: Juffermans N P; Dekkers P E; Verbon A; Speelman P; van Deventer S J; van der Poll T
Concurrent upregulation of urokinase plasminogen activator receptor and CD11b during tuberculosis and experimental endotoxemia.
Infection and immunity 2001;69(8):5182-5.
2001: Olszyna D P; Florquin S; Sewnath M; Branger J; Speelman P; van Deventer S J; Strieter R M; van der Poll T
CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection.
The Journal of infectious diseases 2001;184(3):301-7.
2001: Hardwick J C; Van Den Brink G R; Offerhaus G J; Van Deventer S J; Peppelenbosch M P
Leptin is a growth factor for colonic epithelial cells.
Gastroenterology 2001;121(1):79-90.
2001: Colombel J F; Rutgeerts P; Malchow H; Jacyna M; Nielsen O H; Rask-Madsen J; Van Deventer S; Ferguson A; Desreumaux P; Forbes A; Geboes K; Melani L; Cohard M
Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease.
Gut 2001;49(1):42-6.
2001: de Jonge E; Dekkers P E; Creasey A A; Hack C E; Paulson S K; Karim A; Kesecioglu J; Levi M; van Deventer S J; van der Poll T
Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia.
The Journal of infectious diseases 2001;183(12):1815-8.
2001: Juffermans N P; Verbon A; Schultz M J; Hack C E; van Deventer S J; Speelman P; van der Poll T
Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens.
Antimicrobial agents and chemotherapy 2001;45(5):1547-9.
2001: Levels J H; Abraham P R; van den Ende A; van Deventer S J
Distribution and kinetics of lipoprotein-bound endotoxin.
Infection and immunity 2001;69(5):2821-8.
2001: Leemans J C; Juffermans N P; Florquin S; van Rooijen N; Vervoordeldonk M J; Verbon A; van Deventer S J; van der Poll T
Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(7):4604-11.
2001: Olszyna D P; De Jonge E; Dekkers P E; van Deventer S J; van der Poll T
Induction of cell-associated chemokines after endotoxin administration to healthy humans.
Infection and immunity 2001;69(4):2736-8.
2001: Zwijnenburg P J; van der Poll T; Florquin S; van Deventer S J; Roord J J; van Furth A M
Experimental pneumococcal meningitis in mice: a model of intranasal infection.
The Journal of infectious diseases 2001;183(7):1143-6.
2001: Schultz M J; Rijneveld A W; Speelman P; van Deventer S J; van der Poll T
Endogenous interferon-gamma impairs bacterial clearance from lungs during Pseudomonas aeruginosa pneumonia.
European cytokine network 2001;12(1):39-44.
2001: Schultz M J; Wijnholds J; Peppelenbosch M P; Vervoordeldonk M J; Speelman P; van Deventer S J; Borst P; van der Poll T
Mice lacking the multidrug resistance protein 1 are resistant to Streptococcus pneumoniae-induced pneumonia.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(6):4059-64.
2001: Kimmings N; Sewnath M E; Mairuhu W M; Van Zanten A P; Rauws E A; Van Deventer S J; Gouma D J
The abnormal lipid spectrum in malignant obstructive jaundice in relation to endotoxin sensitivity and the result of preoperative biliary drainage.
Surgery 2001;129(3):282-91.
2001: Verbon A; Dekkers P E; ten Hove T; Hack C E; Pribble J P; Turner T; Souza S; Axtelle T; Hoek F J; van Deventer S J; van der Poll T
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):3599-605.
2001: Hardwick J C; van den Brink G R; Offerhaus G J; van Deventer S J; Peppelenbosch M P
NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps.
Oncogene 2001;20(7):819-27.
2001: Juffermans N P; Speelman P; Verbon A; Veenstra J; Jie C; van Deventer S J; van Der Poll T
Patients with active tuberculosis have increased expression of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(4):650-2.
2001: van den Blink B; Juffermans N P; ten Hove T; Schultz M J; van Deventer S J; van der Poll T; Peppelenbosch M P
p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(1):582-7.
2001: Diks S H; van Deventer S J; Peppelenbosch M P
Lipopolysaccharide recognition, internalisation, signalling and other cellular effects.
Journal of endotoxin research 2001;7(5):335-48.
2000: Schreiber S; Fedorak R N; Nielsen O H; Wild G; Williams C N; Nikolaus S; Jacyna M; Lashner B A; Gangl A; Rutgeerts P; Isaacs K; van Deventer S J; Koningsberger J C; Cohard M; LeBeaut A; Hanauer S B
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
Gastroenterology 2000;119(6):1461-72.
2000: Sewnath M E; Levels H H; Oude Elferink R; van Noorden C J; ten Kate F J; van Deventer S J; Gouma D J
Endotoxin-induced mortality in bile duct-ligated rats after administration of reconstituted high-density lipoprotein.
Hepatology (Baltimore, Md.) 2000;32(6):1289-99.
2000: Olszyna D P; Opal S M; Prins J M; Horn D L; Speelman P; van Deventer S J; van der Poll T
Chemotactic activity of CXC chemokines interleukin-8, growth-related oncogene-alpha, and epithelial cell-derived neutrophil-activating protein-78 in urine of patients with urosepsis.
The Journal of infectious diseases 2000;182(6):1731-7.
2000: Schultz M J; Speelman P; Zaat S A; Hack C E; van Deventer S J; van der Poll T
The effect of pseudomonas exotoxin A on cytokine production in whole blood exposed to Pseudomonas aeruginosa.
FEMS immunology and medical microbiology 2000;29(3):227-32.
2000: Juffermans N P; Paxton W A; Dekkers P E; Verbon A; de Jonge E; Speelman P; van Deventer S J; van der Poll T
Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4(+) T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines.
Blood 2000;96(8):2649-54.
2000: Schultz M J; Olszyna D P; de Jonge E; Verbon A; van Deventer S J; van der Poll T
Reduced ex vivo chemokine production by polymorphonuclear cells after in vivo exposure of normal humans to endotoxin.
The Journal of infectious diseases 2000;182(4):1264-7.
2000: van den Brink G R; O'Toole T; Hardwick J C; van den Boogaardt D E; Versteeg H H; van Deventer S J; Peppelenbosch M P
Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase.
Molecular cell biology research communications : MCBRC 2000;4(3):144-50.
2000: Kimmings A N; van Deventer S J; Rauws EAJ; Huibregtse K; Gouma D J
Systemic inflammatory response in acute cholangitis and after subsequent treatment.
The European journal of surgery = Acta chirurgica 2000;166(9):700-5.
2000: Versteeg H H; Nijhuis E; van den Brink G R; Evertzen M; Pynaert G N; van Deventer S J; Coffer P J; Peppelenbosch M P
A new phosphospecific cell-based ELISA for p42/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein.
The Biochemical journal 2000;350 Pt 3():717-22.
2000: Verbon A; Juffermans N P; Speelman P; van Deventer S J; ten Berge I J; Guchelaar H J; van der Poll T
A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans.
Antimicrobial agents and chemotherapy 2000;44(9):2286-90.
2000: Juffermans N P; Florquin S; Camoglio L; Verbon A; Kolk A H; Speelman P; van Deventer S J; van Der Poll T
Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis.
The Journal of infectious diseases 2000;182(3):902-8.
2000: Juffermans N P; Dekkers P E; Peppelenbosch M P; Speelman P; van Deventer S J; van Der Poll T
Expression of the chemokine receptors CXCR1 and CXCR2 on granulocytes in human endotoxemia and tuberculosis: involvement of the p38 mitogen-activated protein kinase pathway.
The Journal of infectious diseases 2000;182(3):888-94.
2000: Lauw F N; Pajkrt D; Hack C E; Kurimoto M; van Deventer S J; van der Poll T
Proinflammatory effects of IL-10 during human endotoxemia.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(5):2783-9.
2000: Versteeg H H; Hoedemaeker I; Diks S H; Stam J C; Spaargaren M; van Bergen En Henegouwen P M; van Deventer S J; Peppelenbosch M P
Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac.
The Journal of biological chemistry 2000;275(37):28750-6.
2000: Juffermans N P; Verbon A; Belisle J T; Hill P J; Speelman P; van Deventer S J; van der Poll T
Mycobacterial lipoarabinomannan induces an inflammatory response in the mouse lung. A role for interleukin-1.
American journal of respiratory and critical care medicine 2000;162(2 Pt 1):486-9.
2000: Schultz M J; Speelman P; Hack C E; Buurman W A; van Deventer S J; van Der Poll T
Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniae.
The Journal of antimicrobial chemotherapy 2000;46(2):235-40.
2000: Peppelenbosch M P; DeSmedt M; Pynaert G; van Deventer S J; Grooten J
Macrophages present pinocytosed exogenous antigen via MHC class I whereas antigen ingested by receptor-mediated endocytosis is presented via MHC class II.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(4):1984-91.
2000: Franco R F; de Jonge E; Dekkers P E; Timmerman J J; Spek C A; van Deventer S J; van Deursen P; van Kerkhoff L; van Gemen B; ten Cate H; van der Poll T; Reitsma P H
The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation.
Blood 2000;96(2):554-9.
2000: Lauw F N; Simpson A J; Hack C E; Prins J M; Wolbink A M; van Deventer S J; Chaowagul W; White N J; van Der Poll T
Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria.
The Journal of infectious diseases 2000;182(1):206-13.
2000: Lauw F N; Simpson A J; Prins J M; van Deventer S J; Chaowagul W; White N J; van der Poll T
The CXC chemokines gamma interferon (IFN-gamma)-inducible protein 10 and monokine induced by IFN-gamma are released during severe melioidosis.
Infection and immunity 2000;68(7):3888-93.
2000: Dekkers P E; Juffermans N P; Hove T t; de Jonge E; van Deventer S J; van Der Poll T
Granulocyte colony-stimulating factor receptors on granulocytes are down-regulated after endotoxin administration to healthy humans.
The Journal of infectious diseases 2000;181(6):2067-70.
2000: Stokkers P C; Huibregtse K; Leegwater A C; Reitsma P H; Tytgat G N; van Deventer S J
Analysis of a positional candidate gene for inflammatory bowel disease: NRAMP2.
Inflammatory bowel diseases 2000;6(2):92-8.
2000: Juffermans N P; Verbon A; Olszyna D P; van Deventer S J; Speelman P; van Der Poll T
Thalidomide suppresses Up-regulation of human immunodeficiency virus coreceptors CXCR4 and CCR5 on CD4+ T cells in humans.
The Journal of infectious diseases 2000;181(5):1813-6.
2000: Camoglio L; te Velde A A; de Boer A; ten Kate F J; Kopf M; van Deventer S J
Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.
European journal of immunology 2000;30(5):1486-95.
2000: Dekkers P E; ten Hove T; Lauw F N; Koene H R; Lumley P; van Deventer S J; van der Poll T
The metalloproteinase inhibitor GI5402 inhibits endotoxin-induced soluble CD27 and CD16 release in healthy humans.
Infection and immunity 2000;68(5):3036-9.
2000: Kimmings A N; van Deventer S J; Obertop H; Rauws E A; Huibregtse K; Gouma D J
Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage.
Gut 2000;46(5):725-31.
2000: van Aken B E; den Heijer M; Bos G M; van Deventer S J; Reitsma P H
Recurrent venous thrombosis and markers of inflammation.
Thrombosis and haemostasis 2000;83(4):536-9.
2000: Dekkers P E; ten Hove T; te Velde A A; van Deventer S J; van Der Poll T
Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.
Infection and immunity 2000;68(4):2156-60.
2000: van Aken B E; Jansen J; van Deventer S J; Reitsma P H
Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2000;11(2):159-64.
2000: Dekkers P E; Juffermans N P; ten Hove T; de Jonge E; van Deventer S J; van der Poll T
Endotoxin down-regulates monocyte and granulocyte interleukin-6 receptors without influencing gp130 expression in humans.
The Journal of infectious diseases 2000;181(3):1055-61.
2000: Lauw F N; ten Hove T; Dekkers P E; de Jonge E; van Deventer S J; van Der Poll T
Reduced Th1, but not Th2, cytokine production by lymphocytes after in vivo exposure of healthy subjects to endotoxin.
Infection and immunity 2000;68(3):1014-8.
2000: Olszyna D P; Pajkrt D; Lauw F N; van Deventer S J; van Der Poll T
Interleukin 10 inhibits the release of CC chemokines during human endotoxemia.
The Journal of infectious diseases 2000;181(2):613-20.
2000: de Jonge E; Dekkers P E; Creasey A A; Hack C E; Paulson S K; Karim A; Kesecioglu J; Levi M; van Deventer S J; van Der Poll T
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
Blood 2000;95(4):1124-9.
2000: Van Deventer S J
Immunotherapy of Crohn's disease.
Scandinavian journal of immunology 2000;51(1):18-22.
2000: Versteeg H H; Evertzen M W; van Deventer S J; Peppelenbosch M P
The role of phosphatidylinositide-3-kinase in basal mitogen-activated protein kinase activity and cell survival.
FEBS letters 2000;465(1):69-73.
1999: Lauw F N; Simpson A J; Prins J M; Smith M D; Kurimoto M; van Deventer S J; Speelman P; Chaowagul W; White N J; van der Poll T
Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis.
The Journal of infectious diseases 1999;180(6):1878-85.
1999: Olszyna D P; Prins J M; Dekkers P E; De Jonge E; Speelman P; Van Deventer S J; Van Der Poll T
Sequential measurements of chemokines in urosepsis and experimental endotoxemia.
Journal of clinical immunology 1999;19(6):399-405.
1999: Pynaert G; Grooten J; van Deventer S J; Peppelenbosch M P
Cysteinyl leukotrienes mediate histamine hypersensitivity ex vivo by increasing histamine receptor numbers.
Molecular medicine (Cambridge, Mass.) 1999;5(10):685-92.
1999: Rutgeerts P; D'Haens G; Targan S; Vasiliauskas E; Hanauer S B; Present D H; Mayer L; Van Hogezand R A; Braakman T; DeWoody K L; Schaible T F; Van Deventer S J
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
Gastroenterology 1999;117(4):761-9.
1999: Dekkers P E; Lauw F N; ten Hove T; te Velde A A; Lumley P; Becherer D; van Deventer S J; van der Poll T
The effect of a metalloproteinase inhibitor (GI5402) on tumor necrosis factor-alpha (TNF-alpha) and TNF-alpha receptors during human endotoxemia.
Blood 1999;94(7):2252-8.
1999: Dekkers P E; Levi M; van Deventer S J; van der Poll T
Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta in chimpanzees.
Infection and immunity 1999;67(10):5480-2.
1999: Van Den Brink G R; Bloemers S M; Van Den Blink B; Tertoolen L G; Van Deventer S J; Peppelenbosch M P
Study of calcium signaling in non-excitable cells.
Microscopy research and technique 1999;46(6):418-33.
1999: Stokkers P C; Reitsma P H; Tytgat G N; van Deventer S J
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.
Gut 1999;45(3):395-401.
1999: Juffermans N P; Verbon A; van Deventer S J; van Deutekom H; Belisle J T; Ellis M E; Speelman P; van der Poll T
Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan.
Infection and immunity 1999;67(8):4295-7.
1999: Lauw F N; te Velde A A; Dekkers P E; Speelman P; Aerts J M; Hack C E; van Deventer S J; van der Poll T
Activation of mononuclear cells by interleukin-12: an in vivo study in chimpanzees.
Journal of clinical immunology 1999;19(4):231-8.
1999: van der Poll T; van Deventer S J
Cytokines and anticytokines in the pathogenesis of sepsis.
Infectious disease clinics of North America 1999;13(2):413-26, ix.
1999: Peppelenbosch M P; DeSmedt M; ten Hove T; van Deventer S J; Grooten J
Lipopolysaccharide regulates macrophage fluid phase pinocytosis via CD14-dependent and CD14-independent pathways.
Blood 1999;93(11):4011-8.
1999: Present D H; Rutgeerts P; Targan S; Hanauer S B; Mayer L; van Hogezand R A; Podolsky D K; Sands B E; Braakman T; DeWoody K L; Schaible T F; van Deventer S J
Infliximab for the treatment of fistulas in patients with Crohn's disease.
The New England journal of medicine 1999;340(18):1398-405.
1999: D'haens G; Van Deventer S; Van Hogezand R; Chalmers D; Kothe C; Baert F; Braakman T; Schaible T; Geboes K; Rutgeerts P
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.
Gastroenterology 1999;116(5):1029-34.
1999: Lauw F N; Dekkers P E; te Velde A A; Speelman P; Levi M; Kurimoto M; Hack C E; van Deventer S J; van der Poll T
Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees.
The Journal of infectious diseases 1999;179(3):646-52.
1999: Stokkers P C; de Heer K; Leegwater A C; Reitsma P H; Tytgat G N; van Deventer S J
Inflammatory bowel disease and the genes for the natural resistance-associated macrophage protein-1 and the interferon-gamma receptor 1.
International journal of colorectal disease 1999;14(1):13-7.
1999: van Milligen de Wit A W; Kuiper H; Camoglio L; van Bracht J; Jones E A; Tytgat G N; van Deventer S J
Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?
European journal of gastroenterology & hepatology 1999;11(2):129-36.
1999: Versteeg H H; van Bergen en Henegouwen P M; van Deventer S J; Peppelenbosch M P
Cyclooxygenase-dependent signalling: molecular events and consequences.
FEBS letters 1999;445(1):1-5.
1999: Verbon A; Juffermans N; Van Deventer S J; Speelman P; Van Deutekom H; Van Der Poll T
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment.
Clinical and experimental immunology 1999;115(1):110-3.
1999: Lemaire L C; van Lanschot J B; Stoutenbeek C P; van Deventer S J; Dankert J; Oosting H; Gouma D J
Thoracic duct in patients with multiple organ failure: no major route of bacterial translocation.
Annals of surgery 1999;229(1):128-36.
1998: van Deventer S J
Cytokines and mucosal inflammatory response in Crohn's disease.
The European journal of surgery = Acta chirurgica 1998;164(12):897-901.
1998: Juffermans N P; Verbon A; van Deventer S J; Buurman W A; van Deutekom H; Speelman P; van der Poll T
Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis.
The Journal of infectious diseases 1998;178(6):1839-42.
1998: Manten A; de Winter R J; Minnema M C; ten Cate H; Lijmer J G; Adams R; Peters R J; van Deventer S J
Procoagulant and proinflammatory activity in acute coronary syndromes.
Cardiovascular research 1998;40(2):389-95.
1998: Lemaire L C; van der Poll T; van Lanschot J J; Endert E; Buurman W A; van Deventer S J; Gouma D J
Minimally invasive surgery induces endotoxin-tolerance in the absence of detectable endotoxemia.
Journal of clinical immunology 1998;18(6):414-20.
1998: Camoglio L; Te Velde A A; Tigges A J; Das P K; Van Deventer S J
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease.
Inflammatory bowel diseases 1998;4(4):285-90.
1998: Prins J M; Lauw F N; Derkx B H; Speelman P; Kuijper E J; Dankert J; van Deventer S J
Endotoxin release and cytokine production in acute and chronic meningococcaemia.
Clinical and experimental immunology 1998;114(2):215-9.
1998: Minnema M C; Pajkrt D; Wuillemin W A; Roem D; Bleeker W K; Levi M; van Deventer S J; Hack C E; ten Cate H
Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia.
Blood 1998;92(9):3294-301.
1998: van Dullemen H M; Wolbink G J; Wever P C; van der Poll T; Hack C E; Tytgat G N; van Deventer S J
Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease.
Scandinavian journal of gastroenterology 1998;33(10):1094-8.
1998: Meenan J; Spaans J; Grool T A; Lammers K; Pals S; Tytgat G N; van Deventer S J
Variation in gut-homing CD27-negative lymphocytes in inflammatory colon disease.
Scandinavian journal of immunology 1998;48(3):318-23.
1998: Lemaire L C; van Lanschot J J; van der Poll T; Buurman W A; van Deventer S J; Gouma D J
Lymph of patients with a systemic inflammatory response syndrome inhibits lipopolysaccharide-induced cytokine production.
The Journal of infectious diseases 1998;178(3):883-6.
1998: Olszyna D P; Prins J M; Buis B; van Deventer S J; Speelman P; van der Poll T
Levels of inhibitors of tumor necrosis factor alpha and interleukin 1beta in urine and sera of patients with urosepsis.
Infection and immunity 1998;66(8):3527-34.
1998: Stokkers P C; van Aken B E; Basoski N; Reitsma P H; Tytgat G N; van Deventer S J
Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
Gut 1998;43(1):33-9.
1998: Grool T A; van Dullemen H; Meenan J; Koster F; ten Kate F J; Lebeaut A; Tytgat G N; van Deventer S J
Anti-inflammatory effect of interleukin-10 in rabbit immune complex-induced colitis.
Scandinavian journal of gastroenterology 1998;33(7):754-8.
1998: Schultz M J; Speelman P; Zaat S; van Deventer S J; van der Poll T
Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood.
Antimicrobial agents and chemotherapy 1998;42(7):1605-9.
1998: de Jonge E; Levi M; Stoutenbeek C P; van Deventer S J
Current drug treatment strategies for disseminated intravascular coagulation.
Drugs 1998;55(6):767-77.
1998: Juffermans N P; Verbon A; van Deventer S J; van Deutekom H; Speelman P; van der Poll T
Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis.
American journal of respiratory and critical care medicine 1998;157(4 Pt 1):1328-31.
1998: van Dullemen H M; de Jong E; Slors F; Tytgat G N; van Deventer S J
Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2: report of two cases.
Diseases of the colon and rectum 1998;41(1):98-102.
1998: Lemaire L C; van Deventer S J; van Lanschot J J; Meenan J; Gouma D J
Phenotypical characterization of cells in the thoracic duct of patients with and without systemic inflammatory response syndrome and multiple organ failure.
Scandinavian journal of immunology 1998;47(1):69-75.
1998: van Montfrans C; Camoglio L; van Deventer S J
Immunotherapy of Crohn's disease.
Mediators of inflammation 1998;7(3):149-52.
1998: van der Poll T; van Deventer S J
The role of interleukin 6 in endotoxin-induced inflammatory responses.
Progress in clinical and biological research 1998;397():365-77.
1997: de Winter R J; Manten A; de Jong Y P; Adams R; van Deventer S J; Lie K I
Interleukin 8 released after acute myocardial infarction is mainly bound to erythrocytes.
Heart (British Cardiac Society) 1997;78(6):598-602.
1997: van Deventer S J
Review article: Chemokine production by intestinal epithelial cells: a therapeutic target in inflammatory bowel disease?
Alimentary pharmacology & therapeutics 1997;11 Suppl 3():116-20; discussion 120-1.
1997: Hommes D W; van Dullemen H M; Levi M; van der Ende A; Woody J; Tytgat G N; van Deventer S J
Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease.
Haemostasis 1997;27(6):269-77.
1997: Lemaire L C; van Lanschot J J; Stoutenbeek C P; van Deventer S J; Wells C L; Gouma D J
Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven.
The British journal of surgery 1997;84(10):1340-50.
1997: Targan S R; Hanauer S B; van Deventer S J; Mayer L; Present D H; Braakman T; DeWoody K L; Schaible T F; Rutgeerts P J
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
The New England journal of medicine 1997;337(15):1029-35.
1997: Pajkrt D; Manten A; van der Poll T; Tiel-van Buul M M; Jansen J; Wouter ten Cate J; van Deventer S J
Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans.
Blood 1997;90(4):1415-24.
1997: Slot W B; Merkus F W; Van Deventer S J; Tytgat G N
Normalization of plasma vitamin B12 concentration by intranasal hydroxocobalamin in vitamin B12-deficient patients.
Gastroenterology 1997;113(2):430-3.
1997: ten Cate J W; van der Poll T; Levi M; ten Cate H; van Deventer S J
Cytokines: triggers of clinical thrombotic disease.
Thrombosis and haemostasis 1997;78(1):415-9.
1997: Wu C G; Hoek F J; Groenink M; Reitsma P H; van Deventer S J; Chamuleau R A
Correlation of repressed transcription of alpha-tocopherol transfer protein with serum alpha-tocopherol during hepatocarcinogenesis.
International journal of cancer. Journal international du cancer 1997;71(4):686-90.
1997: Van Deventer S J
Tumour necrosis factor and Crohn's disease.
Gut 1997;40(4):443-8.
1997: Pajkrt D; van der Poll T; Levi M; Cutler D L; Affrime M B; van den Ende A; ten Cate J W; van Deventer S J
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia.
Blood 1997;89(8):2701-5.
1997: Pajkrt D; Camoglio L; Tiel-van Buul M C; de Bruin K; Cutler D L; Affrime M B; Rikken G; van der Poll T; ten Cate J W; van Deventer S J
Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(8):3971-7.
1997: Stronkhorst A; Radema S; Yong S L; Bijl H; ten Berge I J; Tytgat G N; van Deventer S J
CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study.
Gut 1997;40(3):320-7.
1997: Wu C G; Boers W; Reitsma P R; van Deventer S J; Chamuleau R A
Overexpression of prothymosin alpha, concomitant with c-myc, during rat hepatic carcinogenesis.
Biochemical and biophysical research communications 1997;232(3):817-21.
1997: Pajkrt D; Lerch P G; van der Poll T; Levi M; Illi M; Doran J E; Arnet B; van den Ende A; ten Cate J W; van Deventer S J
Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Thrombosis and haemostasis 1997;77(2):303-7.
1997: Meenan J; Spaans J; Grool T A; Pals S T; Tytgat G N; van Deventer S J
Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.
Gut 1997;40(2):241-6.
1997: Wu C G; Groenink M; Bosma A; Reitsma P H; van Deventer S J; Chamuleau R A
Rat ferritin-H: cDNA cloning, differential expression and localization during hepatocarcinogenesis.
Carcinogenesis 1997;18(1):47-52.
1997: Prins J M; Speelman P; Kuijper E J; Dankert J; van Deventer S J
No increase in endotoxin release during antibiotic killing of meningococci.
The Journal of antimicrobial chemotherapy 1997;39(1):13-8.
1997: Levi M; van der Poll T; ten Cate H; van Deventer S J
The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia.
European journal of clinical investigation 1997;27(1):3-9.
1997: Wu C G; Habib N A; Mitry R R; Reitsma P H; van Deventer S J; Chamuleau R A
Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma.
British journal of cancer 1997;76(9):1199-204.
1997: van Dullemen H; Meenan J; Stronkhorst A; Tytgat G N; van Deventer S J
Mediators of mucosal inflammation: implications for therapy.
Scandinavian journal of gastroenterology. Supplement 1997;223():92-8.
1996: Derkx H H; van den Hoek J; Redekop W K; Bijlmer R P; van Deventer S J; Bossuyt P M
Meningococcal disease: a comparison of eight severity scores in 125 children.
Intensive care medicine 1996;22(12):1433-41.
1996: Snijders F; Meenan J; van den Blink B; van Deventer S J; ten Kate F J
Duodenal intraepithelial and lamina propria T lymphocytes in human immunodeficiency virus-infected patients with and without diarrhoea.
Scandinavian journal of gastroenterology 1996;31(12):1176-81.
1996: Hommes D W; Meenan J; Dijkhuizen S; Ten Kate F J; Tytgat G N; Van Deventer S J
Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis.
Clinical and experimental immunology 1996;106(3):529-33.
1996: Pajkrt D; Doran J E; Koster F; Lerch P G; Arnet B; van der Poll T; ten Cate J W; van Deventer S J
Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.
The Journal of experimental medicine 1996;184(5):1601-8.
1996: Borchiellini A; Fijnvandraat K; ten Cate J W; Pajkrt D; van Deventer S J; Pasterkamp G; Meijer-Huizinga F; Zwart-Huinink L; Voorberg J; van Mourik J A
Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans.
Blood 1996;88(8):2951-8.
1996: Meenan J; Hommes D W; Mevissen M; Dijkhuizen S; Soule H; Moyle M; Büller H R; ten Kate F W; Tytgat G N; van Deventer S J
Attenuation of the inflammatory response in an animal colitis model by neutrophil inhibitory factor, a novel beta 2-integrin antagonist.
Scandinavian journal of gastroenterology 1996;31(8):786-91.
1996: Meenan J; Grool T A; Hommes D W; Dijkhuizen S; ten Kate F J; Wood M; Whittaker M; Tytgat G N; van Deventer S J
Lexipafant (BB-882), a platelet activating factor receptor antagonist, ameliorates mucosal inflammation in an animal model of colitis.
European journal of gastroenterology & hepatology 1996;8(6):569-73.
1996: von der Möhlen M A; van der Poll T; Jansen J; Levi M; van Deventer S J
Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(12):4969-73.
1996: de Jong E; van Dullemen H M; Slors J F; Dekkers P; van Deventer S J; Tytgat G N
Correlation between early recurrence and reoperation after ileocolonic resection in Crohn's disease: a prospective study.
Journal of the American College of Surgeons 1996;182(6):503-8.
1996: Hommes D W; Meenan J; de Haas M; ten Kate F J; von dem Borne A E; Tytgat G N; van Deventer S J
Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation.
Gut 1996;38(4):564-7.
1996: Monajemi H; Meenan J; Lamping R; Obradov D O; Radema S A; Trown P W; Tytgat G N; Van Deventer S J
Inflammatory bowel disease is associated with increased mucosal levels of bactericidal/permeability-increasing protein.
Gastroenterology 1996;110(3):733-9.
1996: Meenan J; Mevissen M; Monajemi H; Radema S A; Soule H R; Moyle M; Tytgat G N; van Deventer S J
Mechanisms underlying neutrophil adhesion to apical epithelial membranes.
Gut 1996;38(2):201-5.
1996: Meenan J; Obradov D O; van Dullemen H; Tytgat G N; van Deventer S J
Use of buffered formaldehyde in the enzymatic digestion of inflamed mucosa.
Journal of clinical pathology 1996;49(2):177-9.
1996: van der Poll T; Jansen J; Levi M; ten Cate H; Hack C E; Aarden L A; ten Cate J W; van Deventer S J
Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.
Scandinavian journal of immunology 1996;43(1):122-5.
1996: van Deventer S J; Camoglio L
Monoclonal antibody therapy of inflammatory bowel disease.
Alimentary pharmacology & therapeutics 1996;10 Suppl 2():107-11; discussion 112.
1995: Kimmings A N; van Deventer S J; Obertop H; Rauws E A; Gouma D J
Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment.
Journal of the American College of Surgeons 1995;181(6):567-81.
1995: Derkx H H; Kuijper E J; Fijen C A; Jak M; Dankert J; van Deventer S J
Inherited complement deficiency in children surviving fulminant meningococcal septic shock.
European journal of pediatrics 1995;154(9):735-8.
1995: Prins J M; van Agtmael M A; Kuijper E J; van Deventer S J; Speelman P
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime.
The Journal of infectious diseases 1995;172(3):886-91.
1995: Bruin K F; Hommes D W; Jansen J; Tytgat G N; Wouter ten Cate J; van Deventer S J
Modulation of cytokine release from human monocytes by drugs used in the therapy of inflammatory bowel diseases.
European journal of gastroenterology & hepatology 1995;7(8):791-5.
1995: van Dullemen H M; van Deventer S J; Hommes D W; Bijl H A; Jansen J; Tytgat G N; Woody J
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).
Gastroenterology 1995;109(1):129-35.
1995: von der Möhlen M A; van Deventer S J; Levi M; van den Ende B; Wedel N I; Nelson B J; Friedmann N; ten Cate J W
Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).
Blood 1995;85(12):3437-43.
1995: van Milligen de Wit A W; van Deventer S J; Tytgat G N
Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies.
The American journal of gastroenterology 1995;90(6):893-900.
1995: Prins J M; Kuijper E J; Mevissen M L; Speelman P; van Deventer S J
Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum.
Infection and immunity 1995;63(6):2236-42.
1995: Snijders F; van Deventer S J; Bartelsman J F; den Otter P; Jansen J; Mevissen M L; van Gool T; Danner S A; Reiss P
Diarrhoea in HIV-infected patients: no evidence of cytokine-mediated inflammation in jejunal mucosa.
AIDS (London, England) 1995;9(4):367-73.
1995: van der Poll T; Levi M; ten Cate H; Jansen J; Biemond B J; Haagmans B L; Eerenberg A; van Deventer S J; Hack C E; ten Cate J W
Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.
Clinical and experimental immunology 1995;100(1):21-5.
1995: Derkx B; Marchant A; Goldman M; Bijlmer R; van Deventer S
High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock.
The Journal of infectious diseases 1995;171(1):229-32.
1995: Jansen J; van der Poll T; Levi M; ten Cate H; Gallati H; ten Cate J W; van Deventer S J
Inhibition of the release of soluble tumor necrosis factor receptors in experimental endotoxemia by an anti-tumor necrosis factor-alpha antibody.
Journal of clinical immunology 1995;15(1):45-50.
1995: Fijnvandraat K; Derkx B; Peters M; Bijlmer R; Sturk A; Prins M H; van Deventer S J; ten Cate J W
Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.
Thrombosis and haemostasis 1995;73(1):15-20.
1995: Stokkers P C; Camoglio L; van Deventer S J
Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy.
Journal of inflammation 1995;47(1-2):97-103.
1995: de Winter R J; von der Möhlen M A; van Lieshout H; Wedel N; Nelson B; Friedmann N; Delemarre B J; van Deventer S J
Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.
Journal of inflammation 1995;45(3):193-206.
1995: Radema S A; Tytgat G N; van Deventer S J
In situ detection of interleukin-1 beta and interleukin 8 in biopsy specimens from patients with ulcerative colitis.
Advances in experimental medicine and biology 1995;371B():1297-9.
1994: van der Poll T; Jansen J; Levi M; ten Cate H; ten Cate J W; van Deventer S J
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees.
The Journal of experimental medicine 1994;180(5):1985-8.
1994: van der Poll T; Jansen J; Endert E; Sauerwein H P; van Deventer S J
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.
Infection and immunity 1994;62(5):2046-50.
1994: Noach L A; Bosma N B; Jansen J; Hoek F J; van Deventer S J; Tytgat G N
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection.
Scandinavian journal of gastroenterology 1994;29(5):425-9.
1994: van der Poll T; Levi M; Hack C E; ten Cate H; van Deventer S J; Eerenberg A J; de Groot E R; Jansen J; Gallati H; Büller H R
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
The Journal of experimental medicine 1994;179(4):1253-9.
1994: Godfried M H; van der Poll T; Weverling G J; Mulder J W; Jansen J; van Deventer S J; Sauerwein H P
Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection.
The Journal of infectious diseases 1994;169(4):739-45.
1994: van der Poll T; van Deventer S J; ten Cate H; Levi M; ten Cate J W
Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.
The Journal of infectious diseases 1994;169(3):665-7.
1994: Lammers K M; Jansen J; Bijlsma P B; Ceska M; Tytgat G N; Laboisse C L; van Deventer S J
Polarised interleukin 8 secretion by HT 29/19A cells.
Gut 1994;35(3):338-42.
1994: Kuipers B; van der Poll T; Levi M; van Deventer S J; ten Cate H; Imai Y; Hack C E; ten Cate J W
Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(5):2438-46.
1994: van der Poll T; Levi M; van Deventer S J; ten Cate H; Haagmans B L; Biemond B J; Büller H R; Hack C E; ten Cate J W
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.
Blood 1994;83(2):446-51.
1994: Levi M; ten Cate H; Bauer K A; van der Poll T; Edgington T S; Büller H R; van Deventer S J; Hack C E; ten Cate J W; Rosenberg R D
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
The Journal of clinical investigation 1994;93(1):114-20.
1994: van der Poll T; Levi M; ten Cate H; van Deventer S J
The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia.
Progress in clinical and biological research 1994;388():425-33.
1994: Jansen J; van der Poll T; van Deventer S J
Endotoxin and the release of tumor necrosis factor receptors.
Progress in clinical and biological research 1994;388():383-97.
1994: Fijnvandraat K; Peters M; Derkx B; van Deventer S; ten Cate J W
Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock.
Progress in clinical and biological research 1994;388():247-54.
1994: ten Cate H; Levi M; van der Poll T; Biemond B J; van Deventer S J; Buller H R; ten Cate J W
Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications.
Progress in clinical and biological research 1994;388():215-9.
1993: Portegies P; Godfried M H; Hintzen R Q; Stam J; van der Poll T; Bakker M; van Deventer S J; van Lier R A; Goudsmit J
Low levels of specific T cell activation marker CD27 accompanied by elevated levels of markers for non-specific immune activation in the cerebrospinal fluid of patients with AIDS dementia complex.
Journal of neuroimmunology 1993;48(2):241-7.
1993: van der Poll T; Jansen J; van Leenen D; von der Möhlen M; Levi M; ten Cate H; Gallati H; ten Cate J W; van Deventer S J
Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
The Journal of infectious diseases 1993;168(4):955-60.
1993: Wortel C H; van Deventer S J; Aarden L A; Lygidakis N J; Büller H R; Hoek F J; Horikx J; ten Cate J W
Interleukin-6 mediates host defense responses induced by abdominal surgery.
Surgery 1993;114(3):564-70.
1993: van Leenen D; van der Poll T; Levi M; ten Cate H; van Deventer S J; Hack C E; Aarden L A; ten Cate J W
Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(4):2318-25.
1993: Derkx B; Taminiau J; Radema S; Stronkhorst A; Wortel C; Tytgat G; van Deventer S
Tumour-necrosis-factor antibody treatment in Crohn's disease.
Lancet 1993;342(8864):173-4.
1993: ten Cate H; Brandjes D P; Wolters H J; van Deventer S J
Disseminated intravascular coagulation: pathophysiology, diagnosis, and treatment.
New horizons (Baltimore, Md.) 1993;1(2):312-23.
1993: van Deventer S J; Hart M; van der Poll T; Hack C E; Aarden L A
Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans.
The Journal of infectious diseases 1993;167(2):461-54.
1993: Godfried M H; van der Poll T; Jansen J; Romijin J A; Schattenkerk J K; Endert E; van Deventer S J; Sauerwein H P
Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection.
AIDS (London, England) 1993;7(1):33-6.
1992: Wortel C H; von der Möhlen M A; van Deventer S J; Sprung C L; Jastremski M; Lubbers M J; Smith C R; Allen I E; ten Cate J W
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.
The Journal of infectious diseases 1992;166(6):1367-74.
1992: van der Poll T; van Deventer S J; Pasterkamp G; van Mourik J A; Büller H R; ten Cate J W
Tumor necrosis factor induces von Willebrand factor release in healthy humans.
Thrombosis and haemostasis 1992;67(6):623-6.
1992: van der Poll T; van Deventer S J; Hack C E; Wolbink G J; Aarden L A; Büller H R; ten Cate J W
Effects on leukocytes after injection of tumor necrosis factor into healthy humans.
Blood 1992;79(3):693-8.
1992: Stronkhorst A; Tytgat G N; van Deventer S J
CD4 antibody treatment in Crohn's disease.
Scandinavian journal of gastroenterology. Supplement 1992;194():61-5.
1991: van der Poll T; van Deventer S J; Büller H R; Sturk A; ten Cate J W
Comparison of the early dynamics of systemic prostacyclin release after administration of tumor necrosis factor and endotoxin to healthy humans.
The Journal of infectious diseases 1991;164(3):599-601.
1991: van der Poll T; Levi M; Büller H R; van Deventer S J; de Boer J P; Hack C E; ten Cate J W
Fibrinolytic response to tumor necrosis factor in healthy subjects.
The Journal of experimental medicine 1991;174(3):729-32.
1991: van der Poll T; van Deventer S J; Büller H R; Sturk A; ten Cate J W
Comparison of the early dynamics of coagulation activation after injection of endotoxin and tumor necrosis factor in healthy humans.
Progress in clinical and biological research 1991;367():55-60.
1991: Wortel C H; Ziegler E J; van Deventer S J
Therapy of gram-negative sepsis in man with anti-endotoxin antibodies: a review.
Progress in clinical and biological research 1991;367():161-78.
1991: van Deventer S J; Hack C E; Wolbink C E; Voermans H J; Strack van Schijindel R J; ten Cate J W; Thijs L G
Endotoxin-induced neutrophil activation--the role of complement revisited.
Progress in clinical and biological research 1991;367():101-9.
1990: van der Poll T; Büller H R; ten Cate H; Wortel C H; Bauer K A; van Deventer S J; Hack C E; Sauerwein H P; Rosenberg R D; ten Cate J W
Activation of coagulation after administration of tumor necrosis factor to normal subjects.
The New England journal of medicine 1990;322(23):1622-7.
1990: de Vries I; van Deventer S J; Debets J; Buller H R; ten Cate J W; Pauw W; Statius van Eps L W; Sturk A
Endotoxin-induced cytokines in human septicemia.
Advances in experimental medicine and biology 1990;256():635-40.
1988: Tytgat G N; van Deventer S J
Pouchitis.
International journal of colorectal disease 1988;3(4):226-8.
1988: van Deventer S J; Knepper A; Landsman J; Lawson J; ten Cate J W; Buller H R; Sturk A; Pauw W
Endotoxins in portal blood.
Hepato-gastroenterology 1988;35(5):223-5.
1988: van Deventer S J; Buller H R; ten Cate J W; Sturk A; Pauw W
Endotoxaemia: an early predictor of septicaemia in febrile patients.
Lancet 1988;1(8586):605-9.
1988: van Deventer S J; de Vries I; Statius van Eps L W; Pauw W; Büller H R; Sturk A; ten Cate J W
Endotoxemia, bacteremia and urosepsis.
Progress in clinical and biological research 1988;272():213-24.
1987: van Deventer S J; Pauw W; ten Cate J W; Janssen M E; Büller H R; Sturk A
Clinical evaluation in febrile patients of an optimized endotoxin assay in blood.
Progress in clinical and biological research 1987;231():489-99.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Sander van Deventer

Research Profile (preview)

Chemicals & Drugs

Disorders

Living Beings

Anatomy

Procedures

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Sander van Deventer (preview)

All Publications